Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Status:
Completed
Trial end date:
2018-10-29
Target enrollment:
Participant gender:
Summary
The study aim was to investigate the efficacy and safety of Osilodrostat in patients with
Cushing's syndrome due to causes other than Cushing's disease in Japan.